Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer
- 1 October 2019
- journal article
- research article
- Published by Springer Nature in Genes & Genomics
- Vol. 41 (12) , 1493-1503
Abstract
Bladder cancer (BCa) is a tumor associated with high morbidity and mortality and its incidence is increasing worldwide. However, the pathogenesis of bladder cancer is not well understood.Keywords
Funding Information
- Project Plan Document of Guangxi Key Laboratory Construction (17-259-57)
- Science and Technology Planning Project of Guangdong Province (2017B020209001)
This publication has 30 references indexed in Scilit:
- Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancerCancer and Metastasis Reviews, 2015
- S100A12 and RAGE Expression in Human Bladder Transitional Cell Carcinoma: a Role for the Ligand/RAGE Axis in Tumor Progression?Asian Pacific Journal of Cancer Prevention, 2015
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- Gene Ontology Annotations and ResourcesNucleic Acids Research, 2012
- Utility of Urothelial mRNA Markers in Blood for Staging and Monitoring Bladder CancerUrology, 2012
- Low ANXA10 expression is associated with disease aggressiveness in bladder cancerBritish Journal of Cancer, 2011
- European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility geneHuman Molecular Genetics, 2011
- CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancerInternational Journal of Molecular Medicine, 2010
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000